Ameet Sarpatwari

Ameet Sarpatwari, PhD, JD

Faculty Member of the Center
Member, HMS Center for Bioethics

Ameet Sarpatwari is an Assistant Professor of Medicine at Harvard Medical School and the Assistant Director of the Program On Regulation, Therapeutics, And Law (PORTAL) within the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. His research draws upon his interdisciplinary training as an epidemiologist and lawyer and focuses on the effects of laws and regulations on therapeutic development, approval, use, and related public health outcomes.​Dr. Sarpatwari completed his undergraduate studies at the University of Virginia, where he was a Jefferson Scholar. He subsequently studied epidemiology at the University of Cambridge and law at the University of Maryland, where he was a John L. Thomas Leadership Scholar. Dr. Sarpatwari's current work focuses on risk evaluation and mitigation strategies, biosimilars, orphan drug policy, and drug development and pricing. In addition to his work with the Center for Bioethics, he also serves as a Faculty Affiliate with the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, and the Behavioral Insights Group at the Harvard Kennedy School. He teaches an annual course on public health law at the Chan School.

Publications View
Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug Makers.
Authors: Authors: Kesselheim AS, Rome BN, Sarpatwari A, Avorn J.
Health Aff (Millwood)
View full abstract on Pubmed
The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine.
Authors: Authors: Wang B, Studdert DM, Sarpatwari A, Franklin JM, Landon J, Kesselheim AS.
PLoS One
View full abstract on Pubmed
Factors Influencing Prescription Drug Costs in the United States-Reply.
Authors: Authors: Sarpatwari A, Avorn J, Kesselheim AS.
JAMA
View full abstract on Pubmed
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
Authors: Authors: Kesselheim AS, Avorn J, Sarpatwari A.
JAMA
View full abstract on Pubmed
Balancing benefits and harms: privacy protection policies.
Authors: Authors: Sarpatwari A, Gagne JJ.
Pharmacoepidemiol Drug Saf
View full abstract on Pubmed
Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
Authors: Authors: Yeh JS, Sarpatwari A, Kesselheim AS.
Drug Saf
View full abstract on Pubmed
Navigating the Dermatological Drug Cost Curve.
Authors: Authors: Sarpatwari A, Kesselheim AS.
JAMA
View full abstract on Pubmed
State Initiatives to Control Medication Costs--Can Transparency Legislation Help?
Authors: Authors: Sarpatwari A, Avorn J, Kesselheim AS.
N Engl J Med
View full abstract on Pubmed
Efficacy of the Priority Review Voucher Program.
Authors: Authors: Sarpatwari A, Kesselheim AS.
JAMA
View full abstract on Pubmed
The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Authors: Authors: Sarpatwari A, Kesselheim AS.
PLoS Med
View full abstract on Pubmed

Address: 
Brigham and Women's Hospital
General Medicine-OBC-3030, N2
1620 Tremont St
Boston, MA 02120